Refractory celiac disease

Current Gastroenterology Reports

Volumn 9, Issue 5, 2007, Pages 401-405

  Abdallah, Hari ^b   Leffler, Daniel ^b   Dennis, Melinda ^b   Kelly, Ciarán P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BUDESONIDE; CLADRIBINE; CYCLOSPORIN; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; STEROID; TACROLIMUS; VEGETABLE PROTEIN;

ABNORMAL LABORATORY RESULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELIAC DISEASE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE RESISTANCE; DRUG EFFICACY; DRUG SAFETY; ENTEROPATHY; GENETIC PREDISPOSITION; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; INGESTION; INTESTINE BIOPSY; INTESTINE VILLUS ATROPHY; MALNUTRITION; PATHOGENESIS; PROGNOSIS; REVIEW; RYE; SYMPTOM; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; WHEAT; DIET THERAPY; FEMALE; HOSPITALIZATION; IMMUNOLOGY; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; RISK ASSESSMENT; TREATMENT FAILURE;

CELIAC DISEASE; FEMALE; GLUTEN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 38849182884     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0049-5     Document Type: Review

References (45)

1. Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 2002, 346:180-188.
2. Dieterich W, Esslinger B, Schuppan D: Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003, 132:98-108.
3. Abdulkarim AS, Burgart LJ, See J, Murray JA: Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002, 97:2016-2021.
4. O'Mahony S, Howdle PD, Losowsky MS: Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996, 10:671-680.
5. Pink IJ, Creamer B: Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967, 1:300-304.
6. Ryan BM, Kelleher D: Refractory celiac disease. Gastroenterology 2000, 119:243-251.
7. Trier JS, Falchuk ZM, Carey MC, Schreiber DS: Celiac sprue and refractory sprue. Gastroenterology 1978, 75:307-316.
8. Trier JS: Celiac sprue. N Engl J Med 1991, 325:1709-1719.
9. Trier JS: Diagnosis of celiac sprue. Gastroenterology 1998, 115:211-216.
10. Bagdi E, Diss TC, Munson P, Isaacson PG: Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999, 94:260-264.
11. Mazzarella G, Maglio M, Paparo F, et al.: An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003, 52:57-62.
12. Karell K, Louka AS, Moodie SJ, et al.: HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003, 64:469-477.
13. Al-Toma A, Goerres MS, Meijer JW, et al.: Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006, 4:315-319.
14. Cellier C, Delabesse E, Helmer C, et al.: Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203-208.
15. Katz AJ, Grand RJ: All that flattens is not "sprue." Gastroenterology 1979, 76:375-377.
16. Kuitunen P, Visakorpi JK, Savilahti E, Pelkonen P: Malabsorption syndrome with cow's milk intolerance. Clinical findings and course in 54 cases. Arch Dis Child 1975, 50:351-356.
17. Ghoshal UC, Ghoshal U, Misra A, Choudhuri G: Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol 2004, 4:10.
18. Tursi A, Brandimarte G, Giorgetti G: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003, 98:839-843.
19. Fine KD, Meyer RL, Lee EL: The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997, 112:1830-1838.
20. Sollid LM, Lie BA: Celiac disease genetics: current concepts and practical applications. Clin Gastroentetol Hepatol 2005, 3:843-851.
21. Ciacci C, Mazzacca G: Unintentional gluten ingestion in celiac patients. Gastroenterology 1998, 115:243.
22. Goggins M, Kelleher D: Celiac disease and other nutrient related injuries to the gastrointestinal tract. Am J Gastroenterol 1994, 89(8 Suppl):S2-S17.
23. Kelly CP, Feighery CF, Gallagher RB, Weir DG: Diagnosis and treatment of gluten-sensitive enteropathy. Adv Intern Med 1990, 35:341-363.
24. Leffler DA, Dennis M, Hyett B, et al.: Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007, 5:445-450.
25. Vahedi K, Mascart F, Mary JY, et al.: Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003, 98:1079-1087.
26. Riordan SM, McIver CJ, Wakefield D, et al. Luminal anti-gliadin antibodies in small intestinal bacterial overgrowth. Am J Gastroenterol 1997, 92:1335-1338.
27. Unsworth DJ, Walker-Smith JA: Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr 1985, 4:375-380.
28. Corazza GR, Biagi F, Volta U, et al.: Autoinumme enteropathy and villous atrophy in adults. Lancet 1997, 350:106-109.
29. Isaacson P, Wright DH: Intestinal lymphoma associated with malabsorption. Lancet 1978, 1:67-70.
30. Isaacson PG: Intestinal lymphoma and enteropathy. J Pathol 1995, 177:111-113.
31. Cellier C, Patey N, Mauvieux L, et al.: Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998, 114:471-481.
32. Carbonnel F, Grollet-Bioul L, Brouet JC, et al.: Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998, 92:3879-3886.
33. Murray A, Cuevas EC, Jones DB, Wright DH: Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995, 146:509-519.
34. Olaussen RW, Løvik A, Tollefsen S, et al.: Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol 2005, 3:875-885.
35. Daum S, Ipczynski R, Heine B et al.: Therapy with budesonide in patients with refractory sprue. Digestion 2006, 73:60-68.
36. Barry RE: Coeliac disease and malignancy. Tijdschr Gastroenterol 1973, 16:23-34.
37. Hamilton JD, Chambers RA, Wynn-Williams A: Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease. Lancet 1976, 1(7971):1213-1216.
38. Peters TJ, Jones PE, Wells G: Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to gluten withdrawal in patients with coeliac disease. Clin Sci Mol Med 1978, 55:285-292.
39. Gillett HR, Arnott ID, McIntyre M, et al.: Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002, 122:800-805.
40. Wahab PJ, Crusius JB, Meijer JW, et al.: Cyclosporin in the treatment of adults with refractory coeliac disease - an open pilot study. Aliment Pharmacol Ther 2000, 14:767-774.
41. Rolny P, Sigurionsdottir HA, Remotti H, et al.: Role of immunosuppressive therapy in refractory sprue-like disease. Am J Gastroenterol 1999, 94:219-225.
42. Goerres MS, Meijer JW, Wahab PJ, et al.: Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003, 18:487-494.
43. Verbeek WH, Mulder CJ, Zweegman S: Alemtuzumab for refractory celiac disease. N Engl J Med 2006, 355:1396-1397.
44. Al-Toma A, Goerres MS, Meijer JW, et al.: Cladribine therapy in refractory celiac disease with abberrant T cells. Clin Gastroenterol Hepatol 2006, 4:1322-1327.
45. Al-toma A, Visser OJ, van Roessel HM, et al.: Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007, 109:2243-2249.